EpCAM: Structure and function in health and disease

2013/04/23 by Ulrike Schnell, Vincenzo Cirulli, Ben N.G. Giepmans +1 · 29 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Biology #Cancer #Cancer Cells and Metastasis #Cancer research #Cell #Cell adhesion #Cell adhesion molecule #Cell biology #Epithelial cell adhesion molecule #Genetics #Glycosylation and Glycoproteins Research #Monoclonal and Polyclonal Antibodies Research

paper · pdf · doi:10.1016/j.bbamem.2013.04.018

openalex publication_date 2013/04/23 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Cited by

• A EPCAM Pathogenic Variant in Familial Lynch Syndrome-Associated Colon Cancer: Insights into Genetic Basis and Tumor Microenvironment Characteristics
• Nano Delivery Strategy Opens Effective Avenues for the Treatment of Colorectal Cancer
• Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation
• The Use of BEREP4 Immunohistochemistry Staining for Detection of Basal Cell Carcinoma
• Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2. [europepmc]
• By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis. [europepmc]
• Cancer Cell-Derived Extracellular Vesicles Are Associated with Coagulopathy Causing Ischemic Stroke via Tissue Factor-Independent Way: The OASIS-CANCER Study. [europepmc]
• Multicolor Electron Microscopy for Simultaneous Visualization of Multiple Molecular Species. [europepmc]
• Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease. [europepmc]
• Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification. [europepmc]
• EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs. [europepmc]
• Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma. [europepmc]
• Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease. [europepmc]
• Functions of EpCAM in physiological processes and diseases (Review). [europepmc]
• The expansion of targetable biomarkers for CAR T cell therapy. [europepmc]
• The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy. [europepmc]
• Biology and clinical relevance of EpCAM. [europepmc]
• Revisiting the Roles of Pro-Metastatic EpCAM in Cancer. [europepmc]
• In silico design and validation of high-affinity RNA aptamers targeting epithelial cellular adhesion molecule dimers. [europepmc]
• Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells. [europepmc]
• Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. [europepmc]
• Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia. [europepmc]
• Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy. [europepmc]
• CAR-T cells for Colorectal Cancer: Target-selection and strategies for improved activity and safety. [europepmc]
• Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. [europepmc]
• Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition. [europepmc]
• Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis. [europepmc]
• Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme. [europepmc]
• The role of N-glycosylation modification in the pathogenesis of liver cancer. [europepmc]